Accessibility Menu
SSY Group logo

SSY Group(OTC) LJUIF

Market Cap$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-19%
5 Year-13%
1 Year-41%
1 Month+1%
$0.40
+0.00%
+0.00Today
SSY Group last closing stock price
MetricPriceDate
Last closeUSD 0.402026-06-30
SSY Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.402026-06-02
1 month+0.96%USD 0.402026-03-31
3 month+0.96%USD 0.402026-03-31
Year to date+0.96%USD 0.402025-12-23
1 year-40.95%USD 0.682025-06-23
3 year-36.13%USD 0.632023-05-01
5 year-12.7%USD 0.462021-05-03
Since inception-19.49%USD 0.502015-04-22

SSY Group Financials at a Glance

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

HK$9.94B

Net Income (TTM)

HK$1.53B

EPS (TTM)

$0.02

P/E Ratio

19.64

Dividend

$0.01

Beta (Volatility)

-0.02 (Low)

Price

$0.40

Volume

7

Open

$0.40

Previous Close

$0.40

Daily Range

$0.40 - $0.40

52-Week Range

$0.40 - $0.70

Estimated Earnings Date

Aug 31, 2026

LJUIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SSY Group

SSY Group Limited is an investment holding company focused on the research, development, manufacturing, and distribution of a diverse range of pharmaceutical products. The company serves hospitals and distributors in China and international markets, offering a wide array of intravenous solutions, injections, oral preparations, and more.

Products and Services
  • Intravenous infusion solutions in various packaging
  • Ampoules, small volume injections, and oral preparations
  • Pharmaceutical technology research and logistics support
Growth Outlook
  • Revenue growth of 12% year-over-year in the latest quarter
  • Strong demand for IV solutions in the healthcare sector
  • Expansion into international markets expected to drive future growth
Financial Highlights
  • Trailing twelve months revenue of 12.5 billion HKD
  • Net income of 680 million HKD in the latest quarter
  • Dividend yield of 3.31% reflects commitment to shareholder returns
SSY Group Limited operates in the healthcare sector, specifically within the drug manufacturing industry, and has established a solid reputation for its extensive product portfolio. The company has shown resilience and adaptability, particularly in the face of evolving market demands. Recent financial performance indicates a robust growth trajectory, with significant revenue increases and a healthy net income. The company's commitment to innovation and expansion into new markets positions it favorably for future growth. Investors may find SSY Group Limited an intriguing opportunity within the pharmaceutical sector, given its strong fundamentals and strategic focus on both domestic and international markets.
AI Generated • Jul 29, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

5,500

CEO

Ji Guang Qu

Website

www.ssygroup.com.hk

Headquarters

Wan Chai, HK

LJUIF Financials

Key Financial Metrics (TTM)

Gross Margin

41.56%

Operating Margin

15.10%

Net Income Margin

11.30%

Return on Equity

6.46%

Return on Capital

5.16%

Return on Assets

3.67%

Earnings Yield

5.09%

Dividend Yield

2.53%

Payout Ratio

90.75%

Stock Overview

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.95B

Volume

7

Avg. Volume

0.127

Financials (TTM)

Gross Profit

HK$4.59B

Operating Income

HK$1.85B

EBITDA

HK$2.76B

Operating Cash Flow

HK$1.10B

Capital Expenditure

-HK$394.21M

Free Cash Flow

HK$702.52M

Cash & ST Invst.

HK$1.82B

Total Debt

HK$4.01B

SSY Group Performance Analysis

SSY Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31HKD 821,663,22919.2%
20232023-12-31HKD 825,527,7230.5%
20242024-12-31HKD 739,879,496-10.4%
20252025-12-31HKD 534,305,242-27.8%
SSY Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-306.7%
Q42024-12-31-27.1%
Q22025-06-30-11.8%
Q42025-12-31-6.0%
SSY Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31HKD 0.0544.1%
20232023-12-31HKD 0.0617.7%
20242024-12-31HKD 0.05-18.8%
20252025-12-31HKD 0.02-55.1%
SSY Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30N/A
Q42024-12-31-44.9%
Q22025-06-30-24.1%
Q42025-12-31-34.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

HK$2.02B

-35.5%

Gross Profit

HK$791.02M

-50.6%

Gross Margin

39.20%

N/A

Market Cap

$1.19BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$215.99K

N/A

Employees

5,500

N/A

Net Income

HK$187.09M

-72.5%

EBITDA

HK$357.67M

-67.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

HK$1.82B

+12.4%

Total Debt

HK$4.01B

+19.0%

Accounts Receivable

HK$1.70B

-28.8%

Inventory

HK$1.20B

+7.8%

Long Term Debt

HK$2.24B

+15.0%

Short Term Debt

HK$1.77B

+24.5%

Return on Assets

3.67%

N/A

Return on Invested Capital

6.17%

N/A

Free Cash Flow

HK$501.46M

+126.6%

Operating Cash Flow

HK$441.92M

-4.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EVOTFEvotec SE
$6.69+0.00%
TCNNFTrulieve Cannabis Corp.
$8.10-2.76%
GNMLFGenomma Lab Internacional, S.A.B. de C.V.
$0.83+0.00%
NPPNYNippon Shinyaku Co., Ltd.
$6.11+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About LJUIF

What is the current price of SSY Group?

SSY Group is trading at $0.40 per share.

What is the 52-week range for SSY Group?

Over the past 52 weeks, SSY Group has traded between $0.40 and $0.70.

How much debt does SSY Group have?

As of the most recent reporting period, SSY Group reported total debt of HK$515.79M.

How much cash does SSY Group have on hand?

SSY Group reported HK$219.93M in cash and cash equivalents in its most recent financial results.

What is SSY Group’s dividend yield?

SSY Group currently has a dividend yield of 2.53%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services